NeoGenomics, Inc. (NEO) Social Stream
NEOGENOMICS INC (NEO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NEOGENOMICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 9 | $60 | $45 | $51.625 | $15.81 | 226.53% |
| 2021-12-07 | 9 | $60 | $41 | $50.75 | $15.81 | 221% |
| 2021-12-17 | 9 | $60 | $41 | $48.5 | $15.81 | 206.77% |
| 2022-01-06 | 9 | $60 | $41 | $49 | $15.81 | 209.93% |
| 2022-01-12 | 9 | $53 | $41 | $47.125 | $15.81 | 198.07% |
| 2022-01-18 | 9 | $53 | $40 | $45.5 | $15.81 | 187.79% |
| 2022-02-01 | 9 | $53 | $40.001 | $45.5 | $15.81 | 187.79% |
| 2022-02-23 | 9 | $53 | $30 | $43.625 | $15.81 | 175.93% |
| 2022-02-24 | 9 | $50 | $24 | $37 | $15.81 | 134.03% |
| 2022-03-01 | 9 | $50 | $24 | $36.25 | $15.81 | 129.29% |
| 2022-03-29 | 9 | $50 | $16 | $30.875 | $15.81 | 95.29% |
| 2022-03-30 | 9 | $29 | $16 | $20.75 | $15.81 | 31.25% |
| 2022-04-12 | 9 | $28 | $16 | $21.333 | $15.81 | 34.93% |
| 2022-04-14 | 9 | $28 | $16 | $20.666 | $15.81 | 30.71% |
| 2022-04-29 | 9 | $28 | $15 | $20 | $15.81 | 26.5% |
| 2022-05-18 | 9 | $28 | $12 | $18.333 | $15.81 | 15.96% |
| 2022-06-03 | 10 | $28 | $12 | $17.8 | $15.81 | 12.59% |
| 2022-07-19 | 10 | $28 | $9 | $16.8 | $15.81 | 6.26% |
| 2022-08-13 | 11 | $28 | $12 | $17.181 | $15.81 | 8.67% |
| 2022-08-17 | 11 | $28 | $12 | $17.727 | $15.81 | 12.13% |
| 2022-09-17 | 11 | $28 | $13 | $17.818 | $15.81 | 12.7% |
| 2022-10-17 | 10 | $28 | $13 | $17.818 | $15.81 | 12.7% |
| 2022-10-24 | 10 | $28 | $12 | $17.09 | $15.81 | 8.1% |
| 2022-11-01 | 11 | $28 | $10 | $16.818 | $15.81 | 6.38% |
| 2022-11-09 | 10 | $28 | $10 | $17.09 | $15.81 | 8.1% |
| 2022-11-14 | 11 | $28 | $10 | $16.454 | $15.81 | 4.07% |
| 2023-01-06 | 11 | $28 | $10 | $16.5 | $15.81 | 4.36% |
| 2023-01-26 | 11 | $28 | $10 | $16.2 | $15.81 | 2.47% |
| 2023-02-08 | 11 | $28 | $10 | $16.09 | $15.81 | 1.77% |
| 2023-02-27 | 11 | $28 | $10 | $19.363 | $15.81 | 22.47% |
| 2023-03-03 | 11 | $28 | $17 | $20.545 | $15.81 | 29.95% |
| 2023-04-05 | 11 | $25 | $17 | $19.8 | $15.81 | 25.24% |
| 2023-04-21 | 11 | $25 | $17 | $19.7 | $15.81 | 24.6% |
| 2023-05-09 | 11 | $25 | $17 | $19.9 | $15.81 | 25.87% |
| 2023-05-10 | 11 | $28 | $17 | $20.2 | $15.81 | 27.77% |
| 2023-05-14 | 11 | $28 | $17 | $20.6 | $15.81 | 30.3% |
| 2023-06-06 | 12 | $28 | $17 | $21.6 | $15.81 | 36.62% |
| 2023-08-08 | 12 | $25 | $17 | $21.3 | $15.81 | 34.72% |
| 2023-08-14 | 11 | $25 | $17 | $21.222 | $15.81 | 34.23% |
| 2023-10-02 | 11 | $25 | $17 | $20.888 | $15.81 | 32.12% |
| 2023-10-18 | 11 | $25 | $17 | $20.333 | $15.81 | 28.61% |
| 2023-10-20 | 12 | $25 | $15 | $19.8 | $15.81 | 25.24% |
| 2023-10-24 | 12 | $25 | $15 | $19.6 | $15.81 | 23.97% |
| 2023-11-07 | 12 | $25 | $15 | $19.5 | $15.81 | 23.34% |
| 2023-11-08 | 12 | $30 | $16 | $20.1 | $15.81 | 27.13% |
| 2023-12-01 | 12 | $30 | $16 | $20.5 | $15.81 | 29.66% |
| 2023-12-12 | 12 | $30 | $17 | $20.8 | $15.81 | 31.56% |
| 2023-12-27 | 12 | $26 | $17 | $20.4 | $15.81 | 29.03% |
The Trend in the Analyst Price Target
Over the past 31 months, NEO's average price target has gone down $36.87.
NEO reports an average of 26.98% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-21 | 11 | 25 | 17 | 19.700 | 15.99 | 23.2% |
| 2023-05-10 | 11 | 28 | 17 | 20.200 | 19.65 | 2.8% |
| 2023-08-08 | 12 | 25 | 17 | 21.111 | 15.32 | 37.8% |
| 2023-08-14 | 11 | 25 | 17 | 21.222 | 13.94 | 52.24% |
| 2023-11-08 | 12 | 30 | 16 | 20.200 | 15.83 | 27.61% |
NEO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.58 | 8 | 1 | 3 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
NEO's average broker recommendation rating worsened by 0.14 over the prior 23 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, NEOGENOMICS INC's variance in analysts' estimates is lower than -4040.81% of them.
- NEOGENOMICS INC's average analyst price target is greater than 1803.47% of all US stocks.
- NEOGENOMICS INC's number of analysts covering the stock is greater than 4603.4% of stocks in the mid market cap category.
- NEO has a greater upside potential (average analyst target price relative to current price) than 2285.73% of Healthcare stocks.
Stocks similar to NEOGENOMICS INC in the Business Services industry regarding analyst recommendations and price targets are SPT, PRCH, and CRNC.
View All Top Stocks by Price Target
Is NEO a Buy, Hold or Sell? See the POWR Ratings now!